Senator scrutinizes pharma links on government pain panel
from The Associated Press via CNBC
A high-ranking Senate Democrat is scrutinizing links between pharmaceutical companies and government advisers who recently criticized efforts to reduce painkiller prescribing. Sen. Ron Wyden says he has a "number of concerns" about how panelists were selected and screened for an advisory panel on pain issues that includes government experts, outside academics and patient advocates.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063